- Fee assured
- Verified this account
- General urology
- Urinary tract stones
- Urological oncology
Mr Neil Haldar, MBBS (Lon), FRCS (Eng), FRCS (UROL), MD (University of London), graduated from King’s College School of Medicine in 1992 and was a demonstrator in anatomy at Guy’s Hospital, London before joining the Oxford Junior Surgical training scheme.
In 1997 he was awarded the Allinson Foundation Research Fellowship from the Royal College of Surgeons and undertook a Master’s degree at the Nuffield Dept of Surgery in Oxford. Mr Haldar then went on to complete his higher surgical urology training in Oxford following which he undertook further visiting fellowships to the Cleveland Clinic, Ohio and Nantes, France to develop his specialist interest in laparoscopic urology.
In 2005 he was appointed as Clinical Lead in laparoscopic urology to Buckinghamshire NHS Trust. As one of the nominated pelvic cancer surgeons for the Thames Valley Cancer Network he carries out nerve-sparing laparoscopic radical prostatectomy for prostate cancer and radical cystectomy with bladder reconstruction for bladder cancer with excellent continence rates in both procedures. He works closely with a multidisciplinary team that in addition to surgery also offers radical radiotherapy, brachytherapy and chemotherapy.
In 2008 Mr Haldar became one of the first surgeons in the UK to perform single incision transperitoneal and extraperitoneal laparoscopic nephrectomy and pyeloplasty. He has published widely on all aspects of urology and his current main area of research is Enhanced Recovery Surgery.
Areas of interest
• Kidney (renal) cancer • Kidney stones • Prostate disease including prostate cancer • Investigation of blood in the urine • Bladder cancer • Testicular cancer • Scrotal surgery and vasectomy • Circumcision • Urinary tract infections • Erectile dysfunction • Minimal access / invasive surgery • Laparoscopic procedures ('keyhole surgery')
Anaesthetists worked with
Current NHS consultant posts held
Consultant Urological Surgeon and lead in laparoscopic urology at Buckinghamshire Hospitals NHS Trust
Completed an MD Thesis, Department of Surgery, Oxford. Currently exploring the physiological and psychological stress associated with surgery, reducing complications, the length of hospitalization and associated costs. Using a multidisciplinary team approach we have reduced our post-operative hospital stay following radical cystectomy from a national average of 21 days down to an average of 8 days. This work has been published and presented at a number of national conferences.
Specialist interest in laparoscopic urology working within strong clinical networks aimed at providing the highest standards of quality of care. Have undertaken management responsibilities including the Oxford Postgraduate School of Surgery, The Royal Society of Medicine urology section, the Chiltern Hospital medical advisory committee, Thames Valley Cancer Network. Clinical editor for the Royal Society of Medicine quarterly CML-urology and advisor for the National Library for Health
Association of Surgeons of GB and Ireland – short list for Moynihan prize
Royal College of Surgeon’s/Allinson Foundation Research Fellowship
Royal Society of Medicine/GlaxoSmithKline trainee of the year award
BJUI/SIU Overseas Clinical Research award
BAUS/ UROLINK travel award
BAUS Young consultant travel award
(Additional) Languages spoken
- French - Basic
CT Urogram For Haematuria - Unearthing Other Diagnoses: A Study Of 801 Patients European
‘Good is not good enough’ – The story of Karl from Tuttlingen
The impact of the two-week wait rule on the diagnosis and management of bladder cancer in a single UK
Urosepsis and bacteraemia caused by antibiotic-resistant organisms after transrectal ultrasonography-guided prostate biopsy.
Rapid recovery surgery: the role of early enteral feeding to improve surgical outcome following radical cystectomy for invasive bladder cancer.
Oxygen free radical scavenger enzyme polymorphisms in systemic sclerosis.
Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation.
The impact of endothelial nitric oxide synthase polymorphisms on long-term renal allograft outcome.
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis.
Donor cytokine genotype influences the development of acute rejection after renal transplantation.
The impact of recipient cytokine genotype on acute rejection after renal transplantation.
A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer.
Glutathione S-transferase polymorphisms and skin cancer after renal transplantation.
Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers.
How reliable is a vasectomy? Long-term follow-up of vasectomised men.
Courses offered to GPs
Prostate, Renal and Bladder Cancer update
Enhancing the 2 week wait pathway
Enhanced recovery surgery
Advances in minimally invasive surgery
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://www.baus.org.uk/patients/surgical_outcomes/
Please see British Association of Urological Surgeons (BAUS) published national audit data
- MBBS BSc (Hons) King's College School of Medicine and Dentistry, London 1992
- FRCS - Fellow Royal College of Surgeons Royal College of Surgeons of England 1997
- MD - Doctor of Medicine (Masters degree) University of London 2001
Reference number 3683914
Details of entry to specialist register
- FRCS UROL, 2005
Affiliations / memberships
Royal College of Surgeons of England
British Medical Association
Medical Defence Union
General Medical Council
British Association of Urological Surgeons
European Association of Urology
- BMI The Chiltern Hospital, HP16 0EN
- 09:00 - 12:00
- 01494 890890
- BMI The Chiltern Hospital, HP16 0EN
- 14:00 - 20:00
- 01494 890890
- BMI The Shelburne Hospital, HP11 2TR
- 18:00 - 20:00
- 01494 888700
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Private secretary Sue Nash: 01494 764902
The Chiltern Hospital: 01494 890890
The Shelburne Hospital: 01494 888700